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Impaired Counterregulation of 
Hypoglycemia in Type 1 Diabetes 
Mellitus
The Diabetes Control and 
Complications Trial in type 1 diabetes 
(T1DM) unequivocally showed the 
beneﬁ  ts of good glycemic control 
in preventing the complications 
of diabetes. Despite the treatment 
advances of the past decade, today 
iatrogenic hypoglycemia remains the 
major impediment to the appropriate 
control of blood glucose [1]. While 
imperfect insulin replacement places 
the patient at increased risk for 
frequent hypoglycemia, patients with 
T1DM also suffer from compromised 
counterregulatory responses to 
hypoglycemia [2]. The responses 
of all three main counterregulatory 
hormones normally responsible for 
rapid reversal of hypoglycemia are 
severely disrupted in T1DM. First, a 
decrease in plasma glucose cannot 
turn off endogenous insulin secretion 
(which is either insigniﬁ  cant or absent). 
Second, glucagon release during 
hypoglycemia is impaired soon after 
onset of diabetes. Third, epinephrine 
release during hypoglycemia becomes 
progressively defective in T1DM; 
its release is triggered only at lower 
plasma glucose levels, and the maximal 
concentration of epinephrine released 
is also signiﬁ  cantly reduced [3]. This 
decrease in epinephrine response 
during hypoglycemia is accompanied 
by an attenuated autonomic neural 
response, which results in the clinical 
syndrome of impaired awareness of 
hypoglycemia (i.e., lack of the warning 
symptoms of prevailing hypoglycemia). 
Because of the disappearance of 
autonomic symptoms in such patients, 
mild hypoglycemia may occur without 
warning and may proceed unnoticed to 
more advanced and dangerous phases. 
Patients suffering from impaired 
awareness of hypoglycemia in addition 
to defective counterregulation may 





failure (HAAF) describes a clinical 
syndrome apparently resulting 
from antecedent episodes of mild 
hypoglycemia that further degrade 
the counterregulatory response. 
As shown experimentally in people 
without diabetes, recurrent and/or 
recent episodes of hypoglycemia 
are associated with reduced 
sympathoadrenal (epinephrine and 
norepinephrine), symptomatic, and 
cognitive responses to subsequent 
hypoglycemia, impairing all of 
the defense mechanisms required 
for prevention and reversal of 
hypoglycemia [5]. Since patients 
with T1DM have an already reduced 
counterregulatory response (as 
mentioned above), HAAF represents 
a vicious cycle of hypoglycemia 
begetting further—and more severe—
hypoglycemia. The critical role played 
by even mild episodes of hypoglycemia 
is exempliﬁ  ed by studies that show 
that avoidance of hypoglycemia can 
improve the epinephrine response 
and reverse impaired awareness of 
hypoglycemia [6]. Furthermore, 
recent studies have shown 
improvement in the counterregulatory 
response to hypoglycemia in T1DM 
using pharmacological interventions, 
suggesting that hypoglycemia sensing 
plays a role in HAAF [7–9]. 
Nocturnal Hypoglycemia
A particularly important condition, 
observed mainly in T1DM, is 
nocturnal hypoglycemia, which 
may be asymptomatic and often is 
neither suspected nor recognized. 
Plasma glucose is rarely measured 
during sleep, and nocturnal 
hypoglycemia may therefore not be 
conﬁ  rmed. Factors that contribute 
to the development of nocturnal 
hypoglycemia include preceding 
physical activity; imbalance between 
the insulin regimen and the amount, 
content, and timing of meals; and 
alcohol consumption. In addition, 
there may be enhanced sensitivity to 
insulin, and sleep per se is associated 
with a decrease in the autonomic 
response to hypoglycemia [10]. 
Although most episodes of nocturnal 
hypoglycemia are asymptomatic, 
some patients complain of sleep 
disturbances (vivid dreams or 
nightmares), morning headache 
(a “hung-over” sensation), chronic 
fatigue, or mood changes (mainly 
depression). As noted above, 
recurrent episodes of hypoglycemia 
cause further deterioration of the 
counterregulatory response to 
subsequent hypoglycemia. Thus, 
nocturnal hypoglycemia may be an 
important factor in precipitating 
daily hypoglycemia episodes and 
exacerbating HAAF [11]. 
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Awakening from Sleep with 
Hypoglycemia
Although the clinical problem of 
nocturnal hypoglycemia in T1DM 
is well recognized, less is known 
about the mechanisms responsible 
for awakening during episodes of 
nocturnal hypoglycemia, and their 
perturbation in T1DM. Understanding 
these mechanisms is particularly 
important given data on the “dead in 
bed” syndrome, hypothesized to be 
due to a combination of undetected 
autonomic dysfunction and nocturnal 
hypoglycemia that may predispose 
T1DM patients to fatal ventricular 
dysrhythmias [12]. Moreover, probably 
owing to reduced sympathoadrenal 
responses, patients with T1DM are less 
likely to be awakened by hypoglycemia 
[13]. 
Banarer et al. [14] have shown 
that patients with T1DM are 
substantially less likely to be awakened 
by hypoglycemia, and that their 
autonomic responses to hypoglycemia 
are reduced during sleep. In their 
studies, however, hypoglycemia was 
induced before the patients were 
asleep. 
In order to better deﬁ  ne the 
relationship between nocturnal 
hypoglycemia and awakening 
from sleep, Bernd Schultes and 
colleagues studied 16 patients with 
T1DM and 16 healthy controls in 
two experimental conditions: (1) 
insulin-induced hypoglycemia (40 
mg/dl) during sleep together with 
polysomnographic measurements and 
serial determination of the hormonal 
counterregulatory response, and (2) 
the same experimental protocol, but 
with maintenance of euglycemia. The 
researchers now report their ﬁ  ndings in 
PLoS Medicine [15]. 
The goal of the study was to 
determine the occurrence of 
awakening during the period of 
hypoglycemia and its correlation to the 
hormonal counterregulatory response. 
There were three important ﬁ  ndings. 
First, only one of the 16 patients with 
T1DM had spontaneous awakening 
during hypoglycemia, whereas ten of 
the 16 healthy controls were awakened 
by hypoglycemia. Second, the 
hormonal counterregulatory response 
to hypoglycemia was (as expected) 
diminished in the patients with T1DM. 
Finally, in all cases of awakening during 
hypoglycemia, there was an associated 
increase in plasma epinephrine and 
cortisol, suggesting a relationship 
between the counterregulatory 
response (i.e., recovery of low blood 
glucose levels) and awakening from 
sleep.
Clinical Implications of Nocturnal 
Hypoglycemia in T1DM
Prevention of nocturnal hypoglycemia 
involves several strategies, including 
“ﬁ  ne tuning” of the insulin regimen, 
the use of “long-acting” bedtime snacks, 
routine monitoring of blood glucose 
at bedtime and before breakfast, and 
occasional monitoring of glucose at 
the time of maximum risk during sleep 
[16]. The development of continuous 
noninvasive glucose-monitoring devices 
is a promising strategy. Not only can 
such devices produce a continuous 
proﬁ  le of blood glucose levels in order 
to better adjust treatment, but they 
also include audible alarms that can 
awaken the patient before the onset of 
dangerous hypoglycemia. 
Schultes and colleagues’ study 
[15] strongly supports and further 
advances the current notion of 
T1DM susceptibility to nocturnal 
hypoglycemia and shows a clear 
relationship between awakening and 
activation of the counterregulatory 
response to hypoglycemia, although a 
cause–effect could not be established 
with this study design. Also, because 
of the rapid onset of hypoglycemia, 
glycemic thresholds for awakening 
could not be determined with 
precision, and no ﬁ  rm associations with 
speciﬁ  c counterregulatory hormones 
could be made. 
Additional studies are needed 
to examine whether the abnormal 
autonomic response in T1DM is 
further impaired during sleep, and 
whether a direct correlation can be 
established between the degree of 
counterregulation impairment (or 
HAAF) and nocturnal awakening 
during hypoglycemia; both factors 
could play important roles in 
the susceptibility to nocturnal 
hypoglycemia in T1DM.  
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